chartexchange

SPRB
Spruce Biosciences, Inc. Common Stock
stockNASDAQ

At CloseOct 15, 2026 3:59:50 PM EDT
41.65USD+6.862%(+2.67)63,772
30.10Bid59.71Ask29.61Spread
Loading…
Loading…
119.70M
Healthcare
Biotechnology
HQ
South San Francisco, CA, USA
Previous Close
$38.98
Beta
1.56
52-Week High
$179.95 2025-10-15
52-Week Low
$38.06 2026-10-14
SMA 50
$51.34
SMA 200
$58.02
Avg. Vol 10D
81,719
Avg. Vol 30D
102,505
Avg. Vol 90D
80,023
Relative Vol
0.56
2.16M
2.1200%
Nov 9, 2026 (25d)
Aug 7, 2025 · 1-for-75 (reverse)
SPRB Profile

spruce biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.

SPRB Performance
PeriodPriceDateChangeBeta
1W45.542026-10-08-8.54%-0.115
1M55.172026-09-15-24.50%0.407
3M45.442026-07-15-8.34%1.228
6M69.322026-04-15-39.92%1.759
1Y159.062025-10-15-73.81%1.559
2Y0.472024-10-15+8814.81%—
5Y4.482021-10-15+829.69%-0.057
SPRB Stock Summary

Spruce Biosciences, Inc. Common Stock (NASDAQ:SPRB) stock price today is $41.65, and today's volume is 57,664. SPRB is up 6.850% today. The 30 day average volume is 102,505. SPRB market cap is $119.70M with 2.87M shares outstanding.